The influence of alprazolam on the monoaminergic neurotransmitter systems in dysthymic patients. Relationship to clinical response

Pharmacopsychiatry

Volumn 31, Issue 4, 1998, Pages 131-136

  Santagostino, C ^a   Cucchi, Maria Laura ^a   Frattini, P ^a   Zerbi, F ^a   Di Paolo, E ^a   Preda, Stefania ^a   Corona, G L ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; ADRENALIN; ALPRAZOLAM; CATECHOLAMINE DERIVATIVE; DOPAMINE; HOMOVANILLIC ACID; SEROTONIN; VANILMANDELIC ACID;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DYSTHYMIA; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MONOAMINERGIC SYSTEM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 15444351795     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979314     Document Type: Article

References (29)

1. Akiskal, H. S.: Dysthymia: clinical and external validity. Acta Psychiatr. Scand. 89 (Suppl.) 383 (1994) 19-23
2. Carroll, B. J., M. Feinberg, J. F. Greden: A specific laboratory test for the diagnosis of melancholia: Standardization, validation and clinical utility. Arch. Gen. Psychiatry 38 (1981) 15-22
3. Clearly, P., W. Guy: Factor analysis of the Hamilton depression scale. Drug Exptl. Clin. Res. 1 (1977) 115-120
4. Corona, G. L., M. L. Cucchi, P. Frattini, G. Santagostino, S. Schinelli, V. Comincioli, F. Zerbi, L. Fenoglio, F. Savoldi: Noradrenergic output and clinical response in depressed women during amitriptyline therapy. Pharmacopsychiatry 22 (1989) 144-151
5. Feighner, J. P., G. C. Adden, L. C. Fabre, K. Rickels, W. T. Smith: Comparison of alprazolam, imipramine and placebo in the treatment of depression.J. Amer. Med. Ass. 249 (1983) 3057-3064
6. Frattini, P., G. Santagostino, S. Schinelli, M. L. Cucchi, G. L. Corona: Assay of urinary vanilmandelic, homovanillic and 5-hydroxyindole acetic acids by liquid chromatography with electrochemical detection. J. Pharmacol. Methods 10 (1983) 193-198
7. Halbrugge, T., T. Gerhardt, J. Ludwig, E. Heidbreder, K. Graef: Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stress. Life Sci. 43 (1988) 19-26
8. Hamilton, M.: A rating scale for depression. J. Neurol. Neurosurg. 23 (1960) 56-62
9. Howland, R. H.: Pharmacotherapy of dysthymia: a review. J. Clin. Psychopharmacol. 11 (1991) 83-92
10. Howland, R. H., M. E. Thase: Biological studies of dysthymia. Biol. Psychiatry 30 (1991) 283-304
11. Javaid, J. I., T. S. Liu, J. W. Maas, J. M. Davis: Measurement of 3-Methoxy-4-hydroxyphenylacetic acid (HVA) in plasma by High Performance Liquid Chromatography with Electrochemical Detector (HPLC-EC). Anal. Biochem. 135 (1983) 326-331
12. Jonas, J. M., M. S. Cohon: A comparison of the safety and efficacy of Alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature. J. Clin. Psychiatry 54 (Suppl.) 10 (1993) 25-45
13. Kirk, R. E.: Experimental design: procedures for the behavioral sciences (II Ed.). Brooks/Cole Publishing Company. Pacific Grove, California (1995)
14. Lapierre, Y. D.: Pharmacological therapy of dysthymia. Acta Psychiatr. Scand. 89 (Suppl.) 383 (1994) 42-48
15. Lapierre, Y. D., M. Browne, K. Oyewumi, D. Sarantidis: Alprazolam and Amitriptyline in the treatment of moderate depression. Int. Clin. Psychopharmacol. 9 (1994) 41-45
16. Lecrubier, Y., P. Boyer, S. Turjanski, W. Rein: Amisulpride versus imipramine and placebo in dysthymia and major depression. J. Affect. Disord. 43 (1997) 95-103
17. Michelini, S., G. B. Cassano, F. Frare, G. Perugi: Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiat. 29 (1996) 127-134
18. Ortiz, J., F. Artigas, E. Gelpi: Serotonergic status in human blood. Life Sci. 43 (1988) 983-990
19. Pearlstein, T. B.: Hormones and depression: What are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Amer. J. Obstet. Gynecol. 173 (1995) 646-653
20. Potter, W. Z., G. Muscettola, F. K. Goodwin: Sources of variance in clinical studies of MHPG. In MHPG: Basic mechanisms and psychopathology. Academic Press Inc., New York, pp. 145-165 (1983)
21. Ravindran, A. V., R. J. Bialik, Y. D. Lapierre: Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test. J. Affect. Disord. 31 (1994) 111-117
22. Suntagostino, G., P. Frattini, S. Schinelli, M. L. Cucchi, G. L. Corona: Urinary 3-methoxy-4-hydroxyphenylglycol determination using reversed-phase chromatography with amperometric detection. J. Chromatogr. 233 (1982) 89-95
23. Santagostino, G., S. Preda, M. L. Cucchi, P. Frattini: Simultaneous measurement of total catecholamines and metanephrines in human urine by liquid chromatography with coulometric detection. Il Farmaco 46 (1991) 1217-1223
24. Schinelli, S., G. Santagostino, P. Frattini, M. L. Cucchi, G. L. Corona: Assay of 3-methoxy-4-hydroxyphenylglycol in human plasma using high-performance liquid chromatography with amperometric detection. J. Chromatogr. 338 (1985) 396-400
25. Stahl, S. M.: The human platelets - A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch. Gen. Psychiatry 34 (1977) 509-516
26. Thase, M. E., M. Fava, U. Halbreich, J. H. Kocsis, L. Koran, J. Davidson, J. Rosenbaum, W. Harrison: A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch. Gen. Psychiatry 53 (1996) 777-784
27. Vanelle, J. M., D. Attarlevy, M. F. Poirier, M. Bouhassira, P. Blin, J. P. Olie: Controlled efficacy study of fluoxetine in dysthymia. Brit. J. Psychiatry 170 (1997) 345-350
28. Weissmann, M. M., P. J. Leaf, M. L. Bruce, L. Florio: The epidemiology of dysthymia in five communities rates: risks, comorbidity, and treatment. Amer. J. Psychiatry 145 (1988) 815-819
29. Zarcone, V. P., K. L. Benson, K. A. Greene, J. G. Csernansky, K. F. Faull: The effect of chronic alprazolam on sleep and monoamine metabolites in depression. J. Clin. Psychopharmacol. 14 (1994) 36-40